Marksans Pharma Limited (NSE:MARKSANS)
India · Delayed Price · Currency is INR 269.30
-3.10 (-1.14%)
Jul 13, 2026, 3:29 PM IST
Marksans Pharma Employees
Marksans Pharma had 1,840 employees as of March 31, 2025. The number of employees increased by 699 or 61.26% compared to the previous year.
Employees
1,840
Change (1Y)
699
Growth (1Y)
61.26%
Revenue / Employee
16.04M INR
Profits / Employee
2.27M INR
Market Cap
122.04B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 1,840 | 699 | 61.26% |
| Mar 31, 2024 | 1,141 | 289 | 33.92% |
| Mar 31, 2023 | 852 | -38 | -4.27% |
| Mar 31, 2022 | 890 | -248 | -21.79% |
| Mar 31, 2021 | 1,138 | -12 | -1.04% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 31,369 |
| Divi's Laboratories | 10,542 |
| Akums Drugs and Pharmaceuticals | 7,337 |
| Park Medi World | 5,911 |
| Metropolis Healthcare | 4,823 |
| Indegene | 4,158 |
Marksans Pharma News
- 5 days ago - Marksans Pharma to acquire ABCnow GmbH for €892,384 - Business Upturn
- 10 days ago - Marksans Pharma announces ₹0.90 per share final dividend for FY26 - Business Upturn
- 10 days ago - Marksans Pharma announces 90% final dividend ahead of AGM - Business Upturn
- 17 days ago - Marksans Pharma submits machine-readable financial results for March 2026 - Business Upturn
- 20 days ago - Marksans Pharma launches campaign to prevent transfer of unclaimed dividends - Business Upturn
- 27 days ago - Marksans Pharma completes acquisition of QliniQ B.V. - Business Upturn
- 5 weeks ago - Marksans Pharma launches 'Saksham Niveshak' campaign to address unclaimed dividends - Business Upturn
- 6 weeks ago - Marksans Pharma to acquire Netherlands-based QliniQ B.V. to expand presence in European markets - Business Upturn